Systems analysis-based assessment of post-treatment adverse events in lymphatic filariasis.
BACKGROUND:Lymphatic filariasis (LF) is a neglected tropical disease, and the Global Program to Eliminate LF delivers mass drug administration (MDA) to 500 million people every year. Adverse events (AEs) are common after LF treatment. METHODOLOGY/PRINCIPAL FINDINGS:To better understand the pathogene...
Main Authors: | Britt J Andersen, Bruce A Rosa, Jonah Kupritz, Aboulaye Meite, Traye Serge, Marla I Hertz, Kurt Curtis, Christopher L King, Makedonka Mitreva, Peter U Fischer, Gary J Weil |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-09-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | https://doi.org/10.1371/journal.pntd.0007697 |
Similar Items
-
Adverse events following single dose treatment of lymphatic filariasis: Observations from a review of the literature.
by: Philip J Budge, et al.
Published: (2018-05-01) -
Impact of annual and semi-annual mass drug administration for Lymphatic Filariasis and Onchocerciasis on Hookworm Infection in Côte d'Ivoire.
by: Agodio Loukouri, et al.
Published: (2020-09-01) -
A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis.
by: Alison Krentel, et al.
Published: (2013-11-01) -
Identification and characterization of Loa loa antigens responsible for cross-reactivity with rapid diagnostic tests for lymphatic filariasis.
by: Marla I Hertz, et al.
Published: (2018-11-01) -
Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
by: Peter U Fischer, et al.
Published: (2017-01-01)